IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $22,185,000 | +149.5% | 260,905 | +4.0% | 7.21% | +181.1% |
| Q2 2020 | $8,892,000 | +9067.0% | 250,905 | +4866.4% | 2.57% | +6009.5% |
| Q1 2019 | $97,000 | -91.7% | 5,052 | -93.9% | 0.04% | -92.8% |
| Q4 2018 | $1,174,000 | -68.3% | 82,254 | -53.8% | 0.58% | -61.7% |
| Q3 2018 | $3,708,000 | -14.4% | 178,000 | -2.7% | 1.52% | -24.9% |
| Q2 2018 | $4,332,000 | +5.6% | 183,000 | -34.9% | 2.03% | +1.6% |
| Q1 2018 | $4,104,000 | -16.5% | 280,900 | -7.6% | 2.00% | -24.5% |
| Q4 2017 | $4,913,000 | -23.7% | 304,000 | -34.0% | 2.65% | -33.8% |
| Q3 2017 | $6,437,000 | +14.3% | 460,451 | -27.8% | 4.00% | -0.5% |
| Q2 2017 | $5,631,000 | +244.6% | 637,700 | +152.5% | 4.02% | +190.7% |
| Q1 2017 | $1,634,000 | -20.4% | 252,574 | -54.9% | 1.38% | -23.4% |
| Q4 2016 | $2,054,000 | +11.5% | 559,674 | -1.3% | 1.80% | +40.7% |
| Q3 2016 | $1,842,000 | -2.6% | 566,796 | -30.5% | 1.28% | -14.4% |
| Q2 2016 | $1,891,000 | – | 815,000 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|